Science never stops. Neither do we! 100K strong, all because of you! Thank you for believing in us. Every follow is more than a number—it’s a step toward groundbreaking discoveries. Here’s to the journey ahead, fueled by insights, innovation and a better scope?of?healthcare. #MedGenome #GeneticTesting #HealthInnovation
MEDGENOME
生物技术研究
Bangalore，Karnataka 101,243 位关注者
Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions
关于我们
MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia. We deliver AI-driven and Validated Genetic testing solutions through new-age proprietary tools and technologies to empower the Clinicians for better management of disease cohorts in rare inherited diseases, reproductive genetics, cancer, eye & neurological disorders, diabetes, cardiovascular diseases and more. Our Genetic Reference Lab at Bangalore is the largest CAP accredited lab in South-East Asia, that offers over 1300 genetic tests across different disease areas such as Oncology, Neurology, Cardiology, Ophthalmology and Rare diseases.
- 网站
-
https://www.medgenome.com
MEDGENOME的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Bangalore，Karnataka
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Integrated Genomics Platform、Onsite next-generation sequencing、Population studies and panel assembly、Rescuing and repurposing compounds & biologics、WGS, WES、RNA Seq、miRNA Seq, ChIP Seq、MethylSeq, TCR Seq、NGS Bioinformatics和Immunotherapy Solutions
地点
MEDGENOME员工
动态
-
Epilepsy affects 50 million people worldwide, with genetics playing a crucial role in diagnosis and treatment. MedGenome’s advanced testing solutions include : - Trio Exome, ExomeMAX & Whole Exome sequencing - Targeted Gene Panels (NGS/MLPA) for SCN1A, epileptic encephalopathy, Myoclonic Epilepsy & more - Microarray testing for microdeletion microduplication syndromes To know more about the relevant genetic testing options and expert genetic counseling, reach out at [email protected] or 1800 296 9696 for more. #EpilepsyAwarnessDay #EpilepsyAwareness #PurpleDay #MedGenome #GeneticTesting
-
Join us for a case-based webinar exploring the role of NGS-based Whole Genome Sequencing in detecting drug resistance in TB. Gain expert insights from Dr. Honey Savla, Consultant - Internal Medicine, Wockhardt Hospital, Mumbai; moderated by Dr. Gunisha Pasricha, Associate Director, MedGenome Labs. Date: 27th March 2025 Time: 7:30 PM onwards Register now: https://lnkd.in/ggUABwgG Every accurate detection can change a life. Stay ahead in TB diagnostics. #MedGenome?#TBDetection?#WholeGenomeSequencing
-
-
Dr. Chanchal Goswami, Senior Consultant – Medical Oncology, Manipal Hospital, Kolkata highlights the importance of early detection of colorectal cancer and how MedGenome’s advanced molecular testing aids in better diagnosis and treatment. Watch now to know more. To learn about relevant genetic testing options, reach out to us at [email protected] or 1800 296 9696. Your health, your move! Get screened, stay informed, and take control of your wellbeing. #MedGenome #GeneticTesting #ColorectalCancer #ColorectalCancerAwareness
-
This World TB Day, let’s explore how advances in genomics and the fight against drug resistance are paving the way to overcome the challenges of tuberculosis. Together, we can #ResistTheResistance .? To know more, visit:?https://lnkd.in/gXWjXvbK #WorldTBDay #Tuberculosis #Genetics
-
Unite to End TB! Drug-resistant TB demands faster, smarter solutions. SPIT SEQ uses Whole Genome Sequencing to detect resistance directly from clinical samples—delivering accurate results in record time. This World TB Day let’s fight TB with innovation. Read more:?https://lnkd.in/g8ZM8uFX #UniteToEndTB?#SPITSEQ #ResistTheResistance #MedGenome
-